Three-dimensional Conformal Radiotherapy for Early Stage Prostatic Cancer : Techniques, Outcomes, and Possible Pitfalls - 07/08/18
Doi : 10.1016/S1055-3207(18)30133-9
Thomas A. Dipetrillo, MD ⁎
From the Department of Radiation Oncology, Tufts University School of Medicine, Boston, Massachusetts
The Department of Radiation Oncology, Brown University School of Medicine, Rhode Island Hospital and Women & Infants Hospital, Providence, Rhode Island
*Address reprint requests to: Thomas A. Dipetrillo, MD, Department of Radiation Oncology, New England Medical Center, 750 Washington Street, Boston, MA 02111Department of Radiation OncologyNew England Medical Center750 Washington StreetBostonMA02111
Résumé |
Advances in radiation therapy have led to the development of multiple methods to deliver radiotherapy accurately to a defined threedimensional target. This technology is most appropriate in the management of early stage prostatic cancer. Precise delivery of radiotherapy can control prostate cancer while minimizing normal tissue (e.g., bladder and rectum) complications.
Le texte complet de cet article est disponible en PDF.© 2000
Elsevier Inc. Tous droits réservés.
Vol 9 - N° 3
P. 435-453 - juillet 2000 Retour au numéro
Article précédent
- Conformal Radiotherapy : What Is It and Why Does It Matter?
- Robert M. Cardinale, Brian D. Kavanagh
- Three-dimensional Conformal Radiation Therapy : What Are the Costs and Benefits?
- Eric M. Horwitz, Gerald E. Hanks
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?